StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.11−0.04 (-3.48%)

Close on Nov 18, 2026Market cap $80.25MP/E –Yield –

InflaRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for InflaRx

InflaRx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More InflaRx figures

See a number that looks wrong?